Impaired glucose tolerance is a more advanced stage of alteration in the glucose metabolism than impaired fasting glucose

被引:28
作者
Guerrero-Romero, F [1 ]
Rodríguez-Morán, M [1 ]
机构
[1] Gen Hosp Mexican Social Secur Inst, Med Res Unit Clin Epidemiol, Inst & Res Grp Diabet & Chron Illnesses, Durango, Mexico
关键词
impaired fasting glucose; impaired glucose tolerance; insulin; Type 2 diabetes mellitus;
D O I
10.1016/S1056-8727(00)00131-8
中图分类号
R5 [内科学];
学科分类号
1002 [临床医学]; 100201 [内科学];
摘要
Background: Recent reports have shown a lack of agreement between the impaired glucose tolerance (1GT) and the impaired fasting glucose (IFG) categories, suggesting that correspond to different impaired glucose metabolism stages. Objective: To determine the differences of serum insulin levels between subjects with IFG and IGT diagnoses. Methods: Cross-sectional study of 52 subjects with IFG and 48 with IGT diagnosis, and a euglycemic group of 140 subjects. Serum glucose and insulin were measured in both fasting and 2-h 75-g oral post-load glucose (2-h PG). Results: Subjects with LFG showed the highest fasting and 2-h PG serum insulin levels, whereas subject with IGT the lowest. Serum insulin values showed no significative changes between the fasting and 2-h PG conditions in the subjects with IGT. whereas the subjects with IFG showed significative hyperinsulinemia. The serum glucose 2-h PG showed an increase of 0.2 mmol/l (CI95% 0.07-0.33), 0.5 mmol/l (CI95% 0.41-0.58) and 3.6 mmol/l (CI95% 3.39-3.81) with respect to basal values, whereas the increase of serum insulin 2-h PG was of 54 pmol/l (CI95% 53.71-55.29), 918 pmol/l (CI95% 917.49-918.51) and 0.5 pmol/l (CI95% 0.15-0.84) for the euglycemic, IFG and IGT subjects, respectively. Conclusions: This study demonstrates that subjects with IFG show hyperinsulinemia whereas those with IGT have Low insulin secretion in response to oral load glucose, suggesting that IFG and IGT correspond to different stages of impaired glucose metabolism. (C) 2001 Elsevier Science inc. All rights reserved.
引用
收藏
页码:34 / 37
页数:4
相关论文
共 20 条
[1]
[Anonymous], 1997, ARCH INTERN MED, V157, P2413, DOI [10.1001/archinte.1997.00440420033005, DOI 10.1001/ARCHINTE.1997.00440420033005]
[2]
RELATIONSHIPS BETWEEN FASTING PLASMA GLUCOSE LEVELS AND INSULIN-SECRETION DURING INTRAVENOUS GLUCOSE-TOLERANCE TESTS [J].
BRUNZELL, JD ;
ROBERTSON, RP ;
LERNER, RL ;
HAZZARD, WR ;
ENSINCK, JW ;
BIERMAN, EL ;
PORTE, D .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1976, 42 (02) :222-229
[3]
RISK-FACTORS FOR NIDDM IN WHITE-POPULATION - PARIS PROSPECTIVE-STUDY [J].
CHARLES, MA ;
FONTBONNE, A ;
THIBULT, N ;
WARNET, JM ;
ROSSELIN, GE ;
ESCHWEGE, E .
DIABETES, 1991, 40 (07) :796-799
[4]
The 1997 American Diabetes Association criteria versus the 1985 World Health Organization criteria for the diagnosis of abnormal glucose tolerance - Poor agreement in the Hoorn study [J].
De Vegt, F ;
Dekker, JM ;
Stehouwer, CDA ;
Nijpels, G ;
Bouter, LM ;
Heine, R .
DIABETES CARE, 1998, 21 (10) :1686-1690
[5]
Concordance between American Diabetes Association and World Health Organization criteria in a northwestern Italian population [J].
Fornengo, P ;
Bruno, A ;
Grassi, G ;
Vineis, P ;
Pagano, G .
DIABETES CARE, 1999, 22 (04) :652-653
[6]
Gavin JR, 1999, DIABETES CARE, V22, pS5
[7]
Comparison of glucose tolerance categories according to World Health Organization and American Diabetes Association diagnostic criteria in a population-based study in Brazil [J].
Gimeno, SGA ;
Ferreira, SRG ;
Franco, LJ ;
Iunes, M .
DIABETES CARE, 1998, 21 (11) :1889-1892
[8]
Do the new screening and diagnostic criteria of diabetes proposed by the American Diabetes Association really match? [J].
Gniuli, D ;
Mingrone, G ;
Strollo, F ;
Strollo, G ;
Greco, AV .
DIABETES CARE, 1999, 22 (02) :367-368
[9]
Lack of agreement between the World Health Organization category of impaired glucose tolerance and the American Diabetes Association category of impaired fasting glucose [J].
Gómez-Pérez, FJ ;
Aguilar-Salinas, CA ;
López-Alvarenga, JC ;
Perez-Jauregui, J ;
Guillen-Pineda, LE ;
Rull, JA .
DIABETES CARE, 1998, 21 (11) :1886-1888
[10]
Guerrero-Romeo F, 1999, Diabetes Care, V22, P527, DOI 10.2337/diacare.22.3.527